| | | 38096 | | 27.06.1973 | | Roche Pharma (Schweiz) AG | | 12.02.2004 | | | | | | | | | | | 10000. | | | | 01.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Madopar 62.5 | Kapseln | Capsules (Levodopa 50 mg, Benserazide 12.5 mg) | N04BA02 | CI | | 02 | Madopar 125 | Kapseln | Capsules (Levodopa 100 mg, Benserazide 25 mg) | N04BA02 | CI |
|
|
